IIB   20738
INSTITUTO DE INVESTIGACIONES BIOLOGICAS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Isolation of a new antimicrobial/antitumor plant peptide: Biotechnological prospects for its use in cancer and infectious diseases therapies
Autor/es:
GUEVARA, MARÍA GABRIELA; MUÑOZ, FERNANDO; MENDIETA, JULIETA; DALEO, GUSTAVO
Reunión:
Conferencia; International Conference on Antimicrobial Research (ICAR 2010); 2010
Resumen:
The immune system of multi-cellular organisms comprises a vast arsenal of mechanisms to protect the host from the constant interactions with infectious microorganisms. Antimicrobial peptides (AMPs) are peptides which protect their hosts against a vast array of microorganisms. These peptides are produced by several species including bacteria, insects, plants, vertebrates and they have been recognized as remotely evolved molecules that have been effectively preserved in mammals. AMPs are expressed on the primary barriers of the organism such as skin and mucosal epithelia, preventing the colonization of host tissues by pathogens. We have previously reported the induction after infection and the cytotoxic activity of potato aspartic proteases (StAPs) towards plant pathogens. Here we show results on the antimicrobial/antitumor activities of these enzymes and a domain from these enzymes, named StAsp-PSI. StAsp-PSI has structural homology with a family of proteins with antimicrobial/antitumor activity, the SAPLIPs family. The results obtained show that StAsp-PSI is able to kill spores of two potato pathogens but not plant cells, in a dose-dependent manner. As reported for StAPs (Solanum tuberosum aspartic proteases), StAsp-PSI ability to kill microbial pathogens is dependent on the direct interaction of the protein with the microbial cell wall/or membrane, leading to increased permeability and lysis. Additionally, we demonstrated that, like proteins of SAPLIP family, StAsp-PSI and StAPs are cytotoxic for Gram negative and Gram positive bacteria in a dose-dependent manner. The amino acid residues conserved in SP_B (pulmonary surfactant protein B) and StAsp-PSI could explain the cytotoxic activity exerted by StAsp-PSI and StAPs against Gram positive bacteria. On the other hand, results obtained show that StAPs induce apoptosis on Jurkat T cells at short time of incubation in a dose dependent manner. However, not significative effect on the T lymphocytes viability was observed at all times and StAPs amounts assayed. StAsp-PSI was able to induce DNA fragmentation; ROS generation and cell cytotoxicity on human breast cancer cells in a dose-dependent manner. These results open a new perspective to analyze these proteins as possible candidates to develop new drugs that would be active against microbes but not against mammalian cells and consider these proteins as conceptually promising agents in cancer therapy.